Open AccessDirect and natural killer cell-mediated antitumor effects of CB1 receptor antagonist rimonabant in human glioblastoma.
Author(s) -
Elena Ciaglia,
Simona Pisanti,
Paola Picardi,
Chiara Laezza,
Giovanni Torelli,
Patrizia Gazzerro,
Maurizio Bifulco
Publication year - 2013
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/conf.fimmu.2013.02.00048
Subject(s) - rimonabant , cannabinoid receptor , cancer research , temozolomide , glioma , cannabinoid , pharmacology , apoptosis , receptor , medicine , chemistry , antagonist , biochemistry